Search research articles
Contact Us
Filters
Showing results (121-130 of 176) with videos related to
Page
of 18
Sort By:
The Lancet Regional Health. Europe
|
July 17, 2025
Prediction of 90-day mortality among cancer patients with unplanned hospitalisation: a retrospective validation study of three prognostic scores
Galip Can Uyar, Oriol Mirallas, Kadriye Başkurt, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 13, 2026
Increased detection of NRG1 fusions in non-squamous non-small cell lung cancer using combined DNA and RNA sequencing in a real-world cohort
Breno Jeha Araújo, Filipe Visani, Rafael Duarte Paes, et al.
Cancers
|
July 29, 2023
Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients
Susana Cedres, Garazi Serna, Alberto Gonzalez-Medina, et al.
Cancer Research Communications
|
December 21, 2023
Weakly Supervised Deep Learning Predicts Immunotherapy Response in Solid Tumors Based on PD-L1 Expression
Marta Ligero, Garazi Serna, Omar S M El Nahhas, et al.
Cancer Discovery
|
May 13, 2015
Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal Cancer
Rodrigo Dienstmann, Amita Patnaik, Rocio Garcia-Carbonero, et al.
NPJ Breast Cancer
|
June 8, 2021
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers
Leticia De Mattos-Arruda, Javier Cortes, Juan Blanco-Heredia, et al.
Molecular Oncology
|
April 25, 2023
Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer centre network
Núria Mulet Margalef, Carmen Castillo, Miguel Mosteiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2020
Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity
Jarle Bruun, Kushtrim Kryeziu, Peter W Eide, et al.
Cancer Medicine
|
April 20, 2026
Progression-Free Survival 2 as a Potential Surrogate for Overall Survival in Glioblastoma: Insights From a Spanish Multicentric Cohort
Jesús Yaringaño, Oriol Mirallas, Víctor Navarro, et al.
Clinical Breast Cancer
|
August 7, 2025
Real-World Treatment Patterns and Outcomes in Hormone Receptor Positive HER2 Negative Early-Stage Breast Cancer in a Private Community Oncology Practice of Brazil
Aline Coelho Gonçalves, Tomas Reinert, Heloisa Mussato Fernandes da Cruz, et al.
Page
of 18
Search research articles
Search
Showing results (121-130 of 176) with videos related to
Sort By:
Page
of 18
The Lancet Regional Health. Europe
|
July 17, 2025
Prediction of 90-day mortality among cancer patients with unplanned hospitalisation: a retrospective validation study of three prognostic scores
Galip Can Uyar, Oriol Mirallas, Kadriye Başkurt, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 13, 2026
Increased detection of NRG1 fusions in non-squamous non-small cell lung cancer using combined DNA and RNA sequencing in a real-world cohort
Breno Jeha Araújo, Filipe Visani, Rafael Duarte Paes, et al.
Cancers
|
July 29, 2023
Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients
Susana Cedres, Garazi Serna, Alberto Gonzalez-Medina, et al.
Cancer Research Communications
|
December 21, 2023
Weakly Supervised Deep Learning Predicts Immunotherapy Response in Solid Tumors Based on PD-L1 Expression
Marta Ligero, Garazi Serna, Omar S M El Nahhas, et al.
Cancer Discovery
|
May 13, 2015
Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal Cancer
Rodrigo Dienstmann, Amita Patnaik, Rocio Garcia-Carbonero, et al.
NPJ Breast Cancer
|
June 8, 2021
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers
Leticia De Mattos-Arruda, Javier Cortes, Juan Blanco-Heredia, et al.
Molecular Oncology
|
April 25, 2023
Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer centre network
Núria Mulet Margalef, Carmen Castillo, Miguel Mosteiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2020
Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity
Jarle Bruun, Kushtrim Kryeziu, Peter W Eide, et al.
Cancer Medicine
|
April 20, 2026
Progression-Free Survival 2 as a Potential Surrogate for Overall Survival in Glioblastoma: Insights From a Spanish Multicentric Cohort
Jesús Yaringaño, Oriol Mirallas, Víctor Navarro, et al.
Clinical Breast Cancer
|
August 7, 2025
Real-World Treatment Patterns and Outcomes in Hormone Receptor Positive HER2 Negative Early-Stage Breast Cancer in a Private Community Oncology Practice of Brazil
Aline Coelho Gonçalves, Tomas Reinert, Heloisa Mussato Fernandes da Cruz, et al.
Page
of 18